EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic characteristics of P. falciparum parasites collected from 2012 to 2016 and anti-malaria resistance along the China-Myanmar border

Mei Li iD, Hui Liu, Linhua Tang, Henglin Yang, Maria Dorina Geluz Bustos, Hong Tu, Pascal Ringwald

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0293590 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Mei Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), Beijing,…. Hauptthemen laut MEDLINE: Antimalarials, Parasites, Artemisinins, Malaria, Falciparum. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization, National Natural Science Foundation of China, WHO Mekong Malaria Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Backgrounds The therapeutic efficacy studies of DHA-PIP for uncomplicated Plasmodium falciparum patients were implemented from 2012 to 2016 along China (Yunnan province)-Myanmar border, which verified the high efficacy of DHA-PIP. With the samples collected in these studies, the genetic characteristics of P . falciparum parasites based on in vivo parasite clearance time (PCT) was investigated to explore if these parasites had developed resistance to DHA and PIP at molecular level.

Methods

The genetic characteristics were investigated based on K13 genotypes, copy numbers of genes pfpm2 and pfmdr1, and nine microsatellite loci (Short Tandem Repeats, STR) flanking the K13 gene on chromosome 13. The PCT 50s were compared based on different K13 genotypes, sites, periods and copy numbers.

Results

In the NW (North-West Yunnan province bordering with Myanmar) region, F446I was the main K13 genotype. No significant differences for PCT 50s presented among three K13 genotypes. In SW (South-West Yunnan province bordering with Myanmar) region, only wild K13 genotype was detected in all parasite isolates whose PCT 50s was significantly longer than those in NW region. For the copy numbers of genes, parasite isolates containing multiple copies of pfmdr1 gene were found in both regions, but only single copy of pfpm2 gene was detected. Though the prevalence of parasite isolates with multiple copies of pfmdr1 gene in SW region was higher than that in NW region, no difference in PCT 50s were presented between isolates with single and multiple copies of pfmdr1 gene. The median He values of F446I group and Others (Non-F446I K13 mutation) group were 0.08 and 0.41 respectively. The mean He values of ML group (Menglian County in SW) and W (wild K13 genotype in NW) group were 0 and 0.69 respectively. The mean F st values between ML and W groups were significantly higher than the other two K13 groups.

Conclusions

P . falciparum isolates in NW and SW regions had very different genetic characteristics. The F446I was hypothesized to have independently appeared and spread in NW region from 2012 and 2016. The high susceptibility of PIP had ensured the efficacy of DHA-PIP in vivo . Multiple copy numbers of pfmdr1 gene might be a potential cause of prolonged clearance time of ACTs drugs along China-Myanmar border.

Trial registration

Trial registration: ISRCTN, ISRCTN 11775446 . Registered 17 April 2020—Retrospectively registered, the registered name was Investigating resistance to DHA-PIP for the treatment of Plasmodium falciparum malaria and chloroquine for the treatment of Plasmodium vivax malaria in Yunnan, China. http://www.isrctn.com/ISRCTN11775446 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsParasitesArtemisininsMalaria, FalciparumMaleAnimalsHumansMyanmarChinaProtozoan ProteinsPlasmodium falciparumDrug Resistance

Substanzen

AntimalarialsArtemisininsProtozoan Proteins

Autor:innen und Institutionen

  • National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), Beijing, China.
  • NHC Key Laboratory of Parasite and Vector Biology, WHO Collaborating Center for Tropical Diseases, Shanghai, China.
  • National Center for International Research on Tropical Diseases, Shanghai, 200025, China.
  • Yunnan Institute of Parasitic Diseases, Yunnan, 665000, China.
  • Office of the WHO Representative to Thailand, Bangkok, 10400, Thailand.
  • Coordinator Director Office, Global Malaria Programme, Geneva, Swizerland.

ORCID-Profile: Mei Li

Förderung

  • World Health Organization
  • National Natural Science Foundation of China
  • WHO Mekong Malaria Programme
  • USAID-PMI
  • Global Fund

Zitieren

APA

Li, M., Liu, H., Tang, L., Yang, H., Bustos, M. D. G., Tu, H., & Ringwald, P. (2023). Genetic characteristics of P. falciparum parasites collected from 2012 to 2016 and anti-malaria resistance along the China-Myanmar border. PLOS ONE. https://doi.org/10.1371/journal.pone.0293590

Vancouver

Li M, Liu H, Tang L, Yang H, Bustos MDG, Tu H, et al. Genetic characteristics of P. falciparum parasites collected from 2012 to 2016 and anti-malaria resistance along the China-Myanmar border. PLOS ONE. 2023. doi:10.1371/journal.pone.0293590

BibTeX
@article{Li2023,
  author = {Li, Mei and Liu, Hui and Tang, Linhua and Yang, Henglin and Bustos, Maria Dorina Geluz and Tu, Hong and Ringwald, Pascal},
  title = {Genetic characteristics of P. falciparum parasites collected from 2012 to 2016 and anti-malaria resistance along the China-Myanmar border},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0293590}
}
Kostenlos starten →